跳至主要内容
临床试验/ISRCTN12460754
ISRCTN12460754进行中(未招募)Unknown

Reducing severe asthma exacerbations by using prescription alerts for excessive reliever inhaler use to target high-risk children: a randomised controlled trial

niversity Hospital Southampton NHS Foundation Trust0 个研究点目标入组 614 人开始时间: 2024年7月4日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
614

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children aged 1-17 years old
  • 2. 7 or more prescriptions of SABA inhalers e.g. salbutamol during the qualifying period (previous 12 months for the intervention group, 24-12 months previously for the control group)
  • 3. Informed consent from parent/guardian/participant with assent from participant where appropriate
  • (Children do not need to have a recorded diagnosis of asthma to be eligible to participate in the project)

排除标准

  • 1. Other (in addition to asthma) long-term respiratory condition e.g. cystic fibrosis.
  • 2. Enrolled in another interventional research study.
  • 3. Participant or parent/guardian unable to communicate sufficiently (with an interpreter where available) to complete consent forms and have an asthma review.

研究者

发起方
niversity Hospital Southampton NHS Foundation Trust

相似试验

Prescription Alerts for Reliever inhalers in... | 临床试验